PRKAA2 and heart disorder: Considering that metformin, a well-known inducer of PRKAA phosphorylation, shows cardiac protection in heart diseases [41], we then examined the therapeutic potential of metformin on crizotinib-induced impaired PRKAA phosphorylation, autophagy process, MET accumulation and cardiac complications.